FDA grants priority review for AbbVie'... - Hepatitis C Support

Hepatitis C Support

683 members359 posts

FDA grants priority review for AbbVie's pan-genotypic HCV regimen

HFIAdmin profile image
0 Replies

It has been weeks since AbbVie's New #Drug Application for glecaprevir/pibrentasvir. At last, the #FDA replied and approved the new regimen. Click below for a recap of the application. #health #HCV #hepatitis

bit.ly/2lczWF9

Written by
HFIAdmin profile image
HFIAdmin
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

Purchase Drugs from Abroad.

I was diagnosed with HepC in May last year, and was told to wait until the new oral drugs were...
Jasm-_1 profile image

Hep c and fed up

Hi everyone, I'm new here I have hep c genotype 1B. I got it through a needle from a tattoo, I've...
Deemon profile image

Hepatitis c

I've just done the 12 weeks treatment which I didn't find so bad I'm getting a wierd thing I've...

Treating myself holistically

I'm new here, i've.had hep c 35 years, treating myself with supplements Wouldn't touch the...
jennyjolly profile image

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.